Interestingly, we found that CMA treatment restored the p-TBK1 level and decreased the p-STAT3 level as well as the levels of the EBV lytic and latent antigens BZLF1, LMP1, and EBNA1 after EBV infection (Fig. 3C and D). This evidence concerns the gene TBK1 and Epstein-Barr virus infection.